Candriam Equities L Oncology Impact I/ LU1864482358 /
| NAV23/05/2024 | Chg.-25.1201 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,851.1899USD | -0.87% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.00 | - |
| 2019 | 10.25 | 6.19 | 2.66 | -3.64 | -2.56 | 8.69 | 0.30 | -0.28 | -3.18 | 5.10 | 7.96 | 5.03 | +41.52% |
| 2020 | -1.46 | -5.35 | -3.07 | 12.12 | 8.54 | 1.42 | 4.43 | 2.15 | 3.52 | -2.21 | 5.82 | 3.86 | +32.43% |
| 2021 | 0.55 | -4.20 | -0.09 | 2.33 | 0.17 | 3.53 | -0.96 | 5.58 | -3.77 | 3.37 | -6.37 | 3.99 | +3.43% |
| 2022 | -10.49 | -1.75 | 4.65 | -5.85 | -1.33 | 0.04 | 4.37 | -3.14 | -4.71 | 7.04 | 6.07 | -3.44 | -9.67% |
| 2023 | 2.16 | -3.88 | 1.38 | 2.83 | -2.56 | 0.08 | 0.89 | -2.02 | -5.25 | -6.36 | 9.21 | 5.73 | +1.11% |
| 2024 | 1.37 | 4.14 | 1.49 | -3.38 | 3.80 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.73% | 10.97% | 11.74% | 14.70% | 17.24% |
| Sharpe ratio | 1.54 | 2.68 | 0.15 | -0.18 | 0.38 |
| Best month | +5.73% | +9.21% | +9.21% | +9.21% | +12.12% |
| Worst month | -3.38% | -3.38% | -6.36% | -10.49% | -10.49% |
| Maximum loss | -6.77% | -6.77% | -15.55% | -25.08% | -25.08% |
| Outperformance | +19.13% | - | +25.64% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,373.6201 | +5.87% | +4.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,536.3999 | +6.01% | +5.00% | |
| Candriam Equities L Oncology Imp... | reinvestment | 205.5000 | +2.36% | -6.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,219.1599 | +3.13% | +15.22% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,592.9000 | +5.53% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 243.5800 | +4.08% | +13.92% | |
| Candriam Equities L Oncology Imp... | paying dividend | 233.5500 | +4.54% | +0.75% | |
| Candriam Equities L Oncology Imp... | paying dividend | 189.1400 | +5.44% | +3.31% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,588.0000 | +1.43% | +1.24% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.0000 | +3.01% | +14.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,089.5901 | +3.32% | -3.48% | |
| Candriam Equities L Oncology Imp... | reinvestment | 258.1100 | +4.96% | +16.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.9800 | +1.94% | -7.27% | |
| Candriam Equities L Oncology Imp... | reinvestment | 283.6000 | +5.42% | +3.29% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.9200 | +3.21% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,830.5000 | +3.46% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,851.1899 | +5.53% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 156.5900 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 271.3500 | +4.54% | +0.73% |
Performance
| YTD | +7.45% | ||
|---|---|---|---|
| 6 Months | +15.19% | ||
| 1 Year | +5.53% | ||
| 3 Years | +3.61% | ||
| 5 Years | +64.12% | ||
| 10 Years | - | ||
| Since start | +90.08% | ||
| Year | |||
| 2023 | +1.11% | ||
| 2022 | -9.67% | ||
| 2021 | +3.43% | ||
| 2020 | +32.43% | ||
| 2019 | +41.52% | ||
